At medXpress Online, we are committed to providing quality healthcare products and excellent customer service. Due to the nature of healthcare products, our return and refund policy is designed to prioritize customer safety and product integrity.

1. Return Eligibility

For safety and quality assurance reasons, we generally do not accept returns of healthcare products once they have been shipped or delivered.

However, you may be eligible for a replacement or refund if:

·         The product arrived damaged during transit.

·         The product was missing from your order.

·         The product received does not match your order confirmation.

Claims must be submitted within 48 hours of delivery.

2. Non-Returnable Items

The following items are not eligible for return or exchange:

·         Opened or used products.

·         Products with broken or removed safety seals.

·         Products stored improperly after delivery.

·         Orders purchased during promotional or clearance sales (unless defective).

·         Products returned without prior authorization.

3. Damaged or Incorrect Orders

If your order arrives damaged or incorrect:

·         Contact our customer support within 48 hours of receiving your order.

·         Provide:

o   Your order number.

o   A description of the issue.

o   Clear photographs of the package and product.

·         Our team will review your request and respond within 2–5 business days.

If approved, we may provide:

·         A replacement product.

·         A partial refund.

·         A full refund, depending on the circumstances.

4. Refund Process

Once your refund request is approved:

·         Refunds will be issued to the original payment method.

·         Processing typically takes 5–10 business days, depending on your payment provider.

·         Shipping charges are generally non-refundable unless the error was caused by medXpress Online.

5. Order Cancellations

·         Orders may be cancelled before they are processed or shipped.

·         Once an order has been dispatched, it cannot be cancelled.

6. Shipping Issues

·         medXpress Online is not responsible for delays caused by:

·         Customs inspections.

·         Severe weather conditions.

·         Courier disruptions.

·         Incorrect shipping information provided by the customer.

7. Contact Us

For return or refund requests, please contact our customer support team with:

·         Full Name

·         Email Address

·         Description of the Issue

·         Supporting Photos (if applicable)

We aim to respond to all inquiries within 1–2 business days.

Important Notice

Healthcare products should be used only as directed by a qualified healthcare professional. For customer safety, products that have been opened, used, or tampered with cannot be returned unless required by applicable law.

About Triluma Cream – Galderma Ltd

Triluma Cream from Galderma Ltd is a topical dermatology healthcare solution containing hydroquinone 4%, tretinoin 0.05%, and fluocinolone acetonide 0.01%. This triple-action formulation is used under professional supervision for the short-term treatment of moderate-to-severe facial melasma.

Product Information

Product Name: Triluma Cream

Active Ingredients: Hydroquinone 4% + Tretinoin 0.05% + Fluocinolone Acetonide 0.01%

Dosage Form: Topical Cream

Drug Classes: Depigmenting Agent + Topical Retinoid + Corticosteroid

Category: Dermatology / Hyperpigmentation & Melasma

Manufacturer/Marketer: Galderma Ltd / Galderma India Pvt Ltd

Prescription Status: Prescription Healthcare Solution

Key Features

• Combines three dermatological active ingredients in one topical formulation.

• Hydroquinone helps reduce melanin production and excess pigmentation.

• Tretinoin supports skin-cell turnover.

• Fluocinolone acetonide helps reduce inflammation and irritation.

• Designed for professionally supervised management of facial melasma.

Common Uses

Healthcare professionals may prescribe Triluma Cream for:

• Moderate-to-severe facial melasma

• Facial hyperpigmentation associated with melasma

• Dark, uneven facial pigmentation associated with melasma

The underlying cause of pigmentation should be professionally evaluated before treatment.

How It Works

Hydroquinone is a depigmenting agent that helps reduce melanin production.

Tretinoin is a topical retinoid that promotes skin-cell turnover and helps improve the appearance of pigmented skin.

Fluocinolone acetonide is a topical corticosteroid that helps reduce inflammation and may lessen irritation associated with the other active ingredients.

Together, these ingredients provide complementary effects for professionally supervised melasma treatment.

Recommended Use

Apply Triluma Cream only as directed by a qualified dermatologist or healthcare professional and follow the applicable product labeling.

For the U.S. formulation, the labeled direction is a thin film once daily at night, at least 30 minutes before bedtime. During the day, appropriate sun protection, including SPF 30 sunscreen and protective clothing, is recommended.

Avoid contact with the eyes, lips, nostrils, mucous membranes, broken skin, or areas not requiring treatment.

Do not use more frequently or for longer than prescribed.

Storage Instructions

• Store according to the manufacturer's specific labeling.

• Keep the cream in its original packaging.

• U.S. TRI-LUMA labeling requires refrigeration at 2–8°C (36–46°F) and protection from freezing. 

• Keep out of reach of children.

• Do not use after the expiration date shown on the packaging.

Important Safety Information

• For external use only.

• May cause redness, peeling, burning, dryness, itching, or irritation at the application site.

• Hydroquinone may rarely cause gradual blue-black discoloration of the skin.

• Prolonged or inappropriate corticosteroid use may cause skin thinning, stretch marks, visible blood vessels, or other skin changes.

• Avoid unnecessary sunlight exposure and use appropriate sun protection.

• Avoid abrasive cleansers, scrubs, or other products that may excessively dry or irritate the skin.

• Do not apply to broken, infected, or severely irritated skin unless specifically directed by a healthcare professional.

• Discuss pregnancy, breastfeeding, or plans for pregnancy with your healthcare professional before use.

• Seek professional advice if severe irritation, swelling, blistering, unusual skin darkening, or other significant reactions occur.

U.S. Regulatory Note

For a U.S.-facing website, TRI-LUMA is a prescription healthcare solution and is FDA-approved for the short-term treatment of moderate-to-severe facial melasma. The U.S. formulation contains hydroquinone 4%, tretinoin 0.05%, and fluocinolone acetonide 0.01%.

Do not describe Triluma as an OTC, non-prescription, cosmetic skin-whitening product, or “no prescription required” healthcare solution.

Important: Verify the exact formulation and labeling of the product being offered. The Indian-market Triluma and U.S. TRI-LUMA may have different labeling, packaging, and distribution requirements.

Disclaimer

The information provided on this page is intended for educational and informational purposes only and should not replace professional medical or dermatological advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, stopping, or changing any prescription healthcare solution.

AI-Generated Image Disclaimer

Image Disclaimer: The product image displayed on this website is AI-generated for illustrative and informational purposes only. The image may differ from the actual product, including its packaging, appearance, color, labeling, tube, texture, or other physical characteristics. The actual product delivered may vary from the image shown. Always refer to the product information and labeling provided with the delivered product.